Charlie Johnson

Charlie Johnson is CEO of ADC Bio.

Contributions

ADCs Assemble

June 13, 2018

Antibody drug conjugates have not yet lived up to their potential, but there is hope – if we turn to the right solutions and techniques.

1 min read